Microrna-889 Promotes Cell Proliferation in Colorectal Cancer by Targeting DAB2IP
Total Page:16
File Type:pdf, Size:1020Kb
European Review for Medical and Pharmacological Sciences 2019; 23: 3326-3334 MicroRNA-889 promotes cell proliferation in colorectal cancer by targeting DAB2IP Y. XIAO1, Z.-H. LI1, Y.-H. BI2 1Laboratory Medicine, Daqing Oilfield General Hospital, Daqing, China. 2Department of Oncology, Qingdao Municipal Hospital, Qingdao, China. Yan Xiao and Zhihong Li contributed equally to this work Abstract. – OBJECTIVE: Colorectal cancer the 5-year overall survival rate for stage I-II CRC (CRC) remains one of the most frequent lethal patients was approximately 90%. However, for malignant tumors worldwide. The correlation stage III patients, it was 60%, while which for between miR-889 expression and CRC progres- stage IV patients was only 8%3. Surgical resec- sion has not been well identified in the recent tion remains the main choice for CRC treatment, literature. Here, we aim to detect the role and mechanism of miR-889 in CRC. and chemotherapy is also suitable for patients 4 PATIENTS AND METHODS: First, miRNA RT- who cannot undergo surgery with stage III-IV . PCR (Real Time-Polymerase Chain Reaction) was More and more biomarkers and new molecular performed to determine miR-889 expression in CRC therapies have gradually been discovered and tissues and cells. The proliferative capacity of cells become new choices for many patients with che- transfected with miR-889 mimics, miR-889 inhibitor motherapy resistance5-7. Previous studies8,9 have or NC was measured by CCK-8 (cell counting kit- 8), colony formation and EdU (5-Ethynyl-2’-deoxyu- found that a large number of genes and complex ridine) assays. The online bioinformatics sites were signaling pathways were involved in the progres- chosen to predict possible downstream regulatory sion of CRC, including oncogene activation, tu- genes of miR-899. The dual-luciferase report as- mor suppressor gene inactivation and epigenetic say was conducted to verify the relation between modification. MicroRNAs (miRNAs) also plays DAB2IP (DAB2 interacting protein) and miR-899. an indispensable role in the CRC progression10. The expression changes of DAB2IP were assessed MiRNAs (microRNAs) are small RNAs con- by quantitative Real Time-Polymerase Chain Reac- tion (qRT-PCR) and Western blot. sisting of 21-25 nucleotides and provide negative 11 RESULTS: MiR-889 was upregulated in CRC post-transcriptional regulation . MiRNAs are tissues and CRC cells, and upregulated miR-889 involved in tumor proliferation, invasion, mi- was confirmed to promote cell growth in vitro. Du- gration angiogenesis, and EMT (epithelial-mes- al-luciferase reporter, qRT-PCR, and Western blot enchymal transition)12,13. MiRNAs also emerged assays suggested that DAB2IP might be regulated in the progression of CRC14. Previous findings15 by miR-889. The effects of miR-889 on proliferation could be abolished by DAB2IP through confirma- have affirmed that miR-1260b could attenuate the tory experiments. By directly targeting DAB2IP, chemosensitivity of CRC cells to 5-fluorouracil miR-889 served as a vital part in accelerating CRC (5-FU). MicroRNA-1258 could reduce the pro- cell proliferation. liferation of CRC cells and be used as an indis- CONCLUSIONS: Our current study substan- pensable target for CRC therapy16. Nevertheless, tiated that miR-889 might participate in con- the mechanism of miR-899 in CRC remains to trolling CRC proliferation by regulating DAB2IP, be explored. which provides potential and prospective ther- apeutic target for CRC. The DAB2 interacting protein (DAB2IP), also known as the ASK1 interacting protein (AIP1), is Key Words MiR-889, CRC, Proliferation, DAB2IP. located at chromosome 9 (q33.1-q33.3) and belongs to the Ras-GAP (Ras-GTPase activating protein) family17,18. DB2IP played a role as a tumor sup- pressor in ovarian cancer19,20, prostate cancer21,22, Introduction breast cancer22, and choriocarcinoma23. In CRC, the EZH2/HDAC1/Snail complex facilitated the CRC (colorectal cancer) remains one of the silence of DAB2IP in CRC cells, thereby pro- most common tumors and the major cause of moting the metastasis of CRC cells24. Also, the cancer-related deaths in the world1,2. Currently, downregulation of DAB2IP increased hnRNPK 3326 Corresponding Author: Yinghui Bi, MM; e-mail: [email protected] Role of miR-889 in CRC levels via the MAPK/ERK signaling pathway. microRNA detection were performed by using Subsequently, the translocation of hnRNPK to the the Hairpin-itTM miRNA qPCR quantification nucleus enhanced the transcriptional activity of kit (GenePharma, Shanghai, China). Specific MMP2, thereby promoting invasion and metasta- primers and internal controls for miRNA and sis of CRC25. However, it remains unknown wheth- mRNA were as follows: miR-889 F: ACACTC- er DAB2IP plays a role in CRC cell proliferation. CAGCTGGGAATGGCTGTCCGTAGT R: TG- In the CRC, the relationship between miR- GTGTCGTGGAGTCG; U6: F: CTCGCTTCGG- 889 and DAB2IP, as well as their expression and CAGCACA R: AACGCTTCACGAATTTGCGT; biological functions, have not been explored. In DAB2IP: F: AGGTGAGTTCATCAAAGCGC R: this study, it was substantiated that miR-889 is GTGGGAAGACACAGTAGGAG; GAPDH: F: an oncogene of CRC and can be used as a target AAGGTGAAGGTCGGAGTCA R: GGAAGAT- for cancer therapy. GGTGATGGGATTT. GAPDH and the small RNA RNU6B (U6) were chosen as an endoge- nous control. The results were shown in relative Patients and Methods expressions calculated by the 2-ΔΔCT method. Tissues Collection Plasmid Transfection We collected 40 pairs of tumors and adja- About 2 × 105 CRC cells were plated onto cent tissues that were resected from colorectal 6-well plates for 24 h. MiR-889 mimics, miR-889 patients in the Daqing Oilfield General Hospital inhibitor, plasmids DAB2IP and siDAB2IP were general surgery since 2018. Before collecting the synthesized by GenePharma (Shanghai, China). tissues, we got the consent of the patient or their Lipofectamine 3000 (Invitrogen, Carlsbad, CA, relatives. This investigation was ratified by the USA) was conducted to transfect in accordance Ethics Committee of Daqing Oilfield General with the manufacturer’ instructions. Hospital. The signed written informed consents were obtained from all patients before the study. Cell Counting Kit-8 (CCK-8) Assay Samples were stored at -80°C after excision and Cell counting kit-8 (CCK-8, Dojindo, Tokyo, prior to RNA extraction. Japan) was utilized to measure the efficiency of cell growth, in accordance with the manufactur- CRC Cell Lines er’s instructions. 1 × 103 cells/well were inoculat- Colorectal cancer cell lines including DLD- ed into 96 wells for culture. 10 µL of the CCK-8 1, HCT116, HT29, SW480, and NCM460 (nor- solution was added to the wells every 24 h. After mal colonic epithelial cells) were obtained from 2 h of incubation, we measured optical density Shanghai Academy of Sciences (Shanghai, Chi- (OD) 450 nm with a microplate reader. na). Colorectal cancer cells and NCM460 were cultured in Dulbecco’s Modified Eagle Medium Colony Formation Assay (DMEM; Gibco, Rockville, MD, USA) supple- Cells were cultured in a 6-well plate with 1 mented with 10% fetal bovine serum (Gibco, × 103 cells/well for 12 days. Next, the cells were Grand Island, NY, USA), 100 U/mL penicillin stained with 0.1% crystal violet staining solution (Gibco, Grand Island, NY, USA) and 100 µg/mL (Beyotime, Shanghai, China) for 15 min. Colo- streptomycin (Gibco, Grand Island, NY, USA) at nies containing at least 50 cells were counted. 37°C in a humidified cell incubator in a 5% CO2 Finally, plates were washed with water and then atmosphere. photographed. MiRNA RT-PCR and Quantitative 5-Ethynyl-2’-Deoxyuridine (EdU) Assay Real Time-Polymerase Chain Reaction To measure proliferation of CRC cells, EdU (qRT-PCR) kit (RiboBio, Guangzhou, China) was chosen. TRIzol reagent (Invitrogen, Carlsbad, CA, Cells were plated onto 24-well plates at 4 × 104 USA) was used to extract total RNA from tis- cells per well for 24 h. On the following day, sues and cells. For qRT-PCR, RNA was further cells were labeled with EdU, fixed with form- reverse transcribed into complementary Deoxyri- aldehyde, and stained with Apollo and 4’,6-di- bose Nucleic Acid (cDNA) by PrimeScript RT kit amidino-2-phenylindole (DAPI) according to the (TaKaRa, Kusatsu, Japan). For miRNA RT-PCR, instructions. Finally, the images were acquired by target-specific reverse transcription and TaqMan a fluorescence microscopy and merged. 3327 Y. Xiao, Z.-H. Li, Y.-H. Bi Bioinformatics Analysis The signals were detected by enhanced chemilu- To search for miR-889 target genes, three on- minescence system (ImageQuant LAS4000 mini, line analysis tools were used (TargetScan, miR- GE, Buckinghamshire, UK). Walk, and miRPathDB). Statistical Analyses Luciferase Report Assay All experimental data were statistically an- The 3’-UTR sequence of DAB2IP predicted alyzed using GraphPad software 7.0 (La Jolla, to bind with miR-889 or a mutated sequence CA, USA) and Statistical Product and Service within the predicted target sites was synthesized Solutions (SPSS) 17.0 (SPSS Inc., Chicago, IL, and inserted into the XbaI and FseI sites of the USA). The p-values were analyzed by perform- pGL3 control vector (Promega, Madison, WI, ing the Student’s t-test, ANOVA test followed by USA). DLD-1 and HCT116 cells were seeded onto Post Hoc Test (Least Significant Difference), and 24-well plates and were then co-transfected with Spearman’s test. p<0.05 for the difference was luciferase reporter vectors and miR-889 mimics considered of statistically significant. or NC by Lipofectamine 3000 (Invitrogen, Carls- bad, CA, USA). The relative luciferase activity was measured with a Dual-Glo Luciferase Assay Results Kit (Promega, Madison, WI, USA). MiR-889 Was Overexpressed Western Blot in Colorectal Cancer The harvested cells were lysed in radioimmu- With the aim of exploring the expression of noprecipitation assay (RIPA) lysis buffer (Beyo- miR-889 in colorectal cancer, miRNA RT-PCR time, Shanghai, China) containing PMSF. Protein was choosen to examine the miR-889 expression was separated by electrophoresis before trans- in 40 cases of CRC tissues and adjacent tissues.